Cure My Disease

Don't miss your cure!

 Log in / Sign up

Art therapy program aims to boost family bonds in vulnerable homes

NCT ID NCT06732297

Knowledge-focused Sponsor: Nanyang Technological University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 10-week art therapy program for vulnerable families in Singapore. Researchers want to see if it improves quality of life and family resilience for parents and children. About 96 families will take part, and their progress will be compared to families not yet in the program. The goal is to learn if the program works and can be used on a larger scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 96 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 99 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (family participant): * the caregiver (including parents, grandparents, family members or foster parents who perform the main caretaking responsibilities of the children taking part in SFAT) of a young child who can communicate in English and provide informed consent * the child is aged 7-14 years and can communicate in English * the family have one or more of the following identified challenges: (1) caregiver stress such as finances, household management, work and childcare arrangements, (2) caregiver struggles to find time for self-care and quality time with children, (3) caregiver has minimal understanding of the psychological and emotional needs of their children, (4) children face difficulties with emotional regulation and anger management * caregivers and children are from low-income families who receive financial assistance under the CHAS Blue card, ComCare financial assistance, and/or the MOE Financial Assistance Scheme Inclusion criteria (art therapist participant) registered art therapist based in the Red Pencil (Singapore) who are in charge of delivering the SFAT programme Inclusion criteria (community staff participant) \- community staff who provides assistance to the implementation of the SFAT programme Exclusion Criteria: * individuals who are suffering from depression or other major mental health conditions that would render their participation highly disruptive to others in a group setting, and/or cannot provide informed consent. Families will also be excluded if they are currently unstable (i.e. circumstances related to abuse/neglect), and/or have high risk of suicidal and self-harm behaviours. In the cases that individuals referred to the programme are not eligible, the partner organisations will assess their needs and refer them to programmes based on these needs. * participant is unable to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Vulnerable families are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Vulnerable families

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Red Pencil Singapore

    RECRUITING

    Singapore, 150082, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.